30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Reimbursement / Regulatory

Nanovis Gains FDA Clearance for Bioceramic Nanotube Surface -

Nanovis received the first FDA 510(k) clearance for a bioceramic nanotube surface that demonstrates FDA's requirements for nanotechnology. The technology is planned to be used with the compaony's entire spinal implant line. Presently the company is commercializing a deeply-porous Ti scaffold available with the FortiCore line of interbody devices, an anterior cervical plating system and open and MIS pedicle screws. Its pipeline includes a bactericidal surface technology and a localized infection technology targeting anti-microbial resistant bacteria, both in pre-clinical studies. (Nanovis, 10/22/19)